Implantica Valuation
| IMP-A-SDB | SEK 35.05 1.40 3.84% |
At this time, the firm appears to be overvalued. Implantica AG retains a regular Real Value of kr30.89 per share. The prevalent price of the firm is kr35.05. Our model calculates the value of Implantica AG from evaluating the firm fundamentals such as Return On Asset of -0.0674, return on equity of -0.15, and Shares Owned By Institutions of 28.58 % as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Implantica's price fluctuation is very steady at this time. Calculation of the real value of Implantica AG is based on 3 months time horizon. Increasing Implantica's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Implantica stock is determined by what a typical buyer is willing to pay for full or partial control of Implantica AG. Since Implantica is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Implantica Stock. However, Implantica's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 35.05 | Real 30.89 | Hype 35.05 |
The intrinsic value of Implantica's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Implantica's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Implantica AG helps investors to forecast how Implantica stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Implantica more accurately as focusing exclusively on Implantica's fundamentals will not take into account other important factors: Implantica Total Value Analysis
Implantica AG is currently estimated to have takeover price of 5.38 B with market capitalization of 5.38 B, debt of 142 K, and cash on hands of 147.29 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Implantica fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.38 B | 5.38 B | 142 K | 147.29 M |
Implantica Investor Information
About 29.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.06. Implantica AG had not issued any dividends in recent years. Based on the key measurements obtained from Implantica's financial statements, Implantica AG is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Implantica Asset Utilization
One of the ways to look at asset utilization of Implantica is to check how much profit was generated for every dollar of assets it reports. Implantica retains a negative application of resources of -0.0674 (percent), losing kr6.74E-4 for each kronor of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each kronor of resources it retains. Simply put, asset utilization of Implantica AG shows how discouraging it operates for each kronor spent on its resources.Implantica Profitability Analysis
The company reported the revenue of 707 K. Net Loss for the year was (15.36 M) with loss before overhead, payroll, taxes, and interest of (867 K).About Implantica Valuation
The stock valuation mechanism determines Implantica's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Implantica AG based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Implantica. We calculate exposure to Implantica's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Implantica's related companies.Implantica AG, a medtech company, researches, develops, and sells medical implants for unmet medical needs in Switzerland. The company was founded in 2015 and is based in Vaduz, Liechtenstein. Implantica is traded on Stockholm Stock Exchange in Sweden.
8 Steps to conduct Implantica's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Implantica's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Implantica's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Implantica's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Implantica's revenue streams: Identify Implantica's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Implantica's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Implantica's growth potential: Evaluate Implantica's management, business model, and growth potential.
- Determine Implantica's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Implantica's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Implantica Stock Analysis
When running Implantica's price analysis, check to measure Implantica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Implantica is operating at the current time. Most of Implantica's value examination focuses on studying past and present price action to predict the probability of Implantica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Implantica's price. Additionally, you may evaluate how the addition of Implantica to your portfolios can decrease your overall portfolio volatility.